Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Arthur McDonald, a Queen’s University professor who shared the 2015 Nobel Prize in Physics, is leading an effort by Canadian scientists at two national laboratories to produce a stripped-down, easy-to-manufacture hospital ventilator in time to meet an urgent demand for the machines because of the COVID-19 pandemic.

Researchers at the TRIUMF particle accelerator in Vancouver and the Canadian Nuclear Laboratories at Chalk River, Ont., are now aiming to complete two working prototypes of their ventilator, one at each location, over the coming week.

“We feel that every country is going to have to have its own made-in-country solution for ventilators," said Dr. McDonald, who is best known for his experimental work involving neutrinos, elusive particles produced in the core of the sun. “The idea is that the capability is here in the particle physics community. We’re just trying to exploit it.”

Story continues below advertisement

How well Canada comes through the COVID-19 pandemic will depend crucially on its supply of ventilators, the complex medical devices that are used to keep patients’ lungs supplied with oxygen when they are unable to breathe on their own.

Dr. McDonald said he became aware of a potential solution when approached by colleagues working with DarkSide, an international physics project based in Italy whose goal is to snare particles of dark matter. The experiment uses argon as its detection medium and its design requires electronic controllers that can precisely regulate gas flow – a capability that is also required of hospital ventilators.

Prompted by the escalating state of the pandemic in Italy, where it has already claimed more than 10,000 lives, Italian researchers on the experiment designed a ventilator last week that is optimized for mass production with inexpensive off-the-shelf parts. The device requires a source of compressed oxygen and electrical power to operate but little else. Unlike conventional ventilators, it has few mechanical parts. Controls and monitoring are contained within an electronics unit that can be accessed via WiFi.

“We need something simple that can be produced at the rate of thousands of units per day," said Cristiano Galbiati, a Princeton University professor who is currently in Milan leading the Italian design.

A prototype is now undergoing a battery of tests in Italy to assess how well it can maintain a patient’s breathing. Dr. Galbiati added that plans for the device will be available to anyone in the world who wants to build one.

“The only thing that is important, if the machine works, is to have it replicated as fast as possible,” he said.

How many coronavirus cases are there in Canada, by province, and worldwide? The latest maps and charts

‘Can I take my kids to the park?’ And more coronavirus questions answered by André Picard

Dr. McDonald said he and his colleagues are now attempting to do exactly that, with modifications to the Italian design to ensure that all parts and materials can be accessed easily within Canada. He added that the Canadian teams are working rapidly and in close contact with each other as the number of severe cases of COVID-19 in the country continues to track upward.

Story continues below advertisement

“It’s quite clear that we’re going to have a real requirement very soon," he said.

Many of those most severely afflicted by COVID-19 require a ventilator to survive long enough to fight off the viral infection. A shortage of the devices would put Canadian doctors in the position of deciding who to save, a situation that has already occurred elsewhere. Uncertainties around how the virus is spreading in Canada and the effectiveness of social-distancing measures currently in effect means it is not yet possible to know if the country will have enough ventilators throughout the course of the pandemic.

Claude Larose, a business adviser with the Medical Devices Research Centre in Montreal, part of the National Research Council, said that he and his colleagues have been working with Dr. McDonald to help facilitate the project on several fronts, including with testing and federal approval if the device can meet compliance standards.

NGen, the federal advanced manufacturing supercluster in Hamilton, which has made $50-million in funding available to companies working on COVID-19-related projects, is also advising Dr. McDonald and NRC on how to scale up production.

Mr. Larose said the best-case scenario for Canada would be that domestic suppliers of hospital ventilators can meet the country’s demands. But as the pandemic progresses, he added, “we need a plan B.”

The Montreal centre is also working on an in-house project to reverse-engineer an older-model ventilator that is no longer in production but was approved for use in the 1960s and would suffice in an emergency situation if it were available today.

Story continues below advertisement

A third approach is the Code Life Ventilator Challenge sponsored by the Montreal General Hospital Foundation. The competition is open to groups around the world with a $200,000 prize for a winning design for an inexpensive ventilator that can meet performance and safety specifications.

The competition was launched on March 17 with a deadline of midnight Tuesday for teams to submit their designs.

Reza Farivar, a faculty member at McGill University and Canada Research Chair in Integrative Neurosciences, is overseeing the competition. He said that its goal is not simply to come up with a single approach to the problem of ventilator supply, but ideally to stimulate a number of viable designs, some of which may be more suitable to addressing the needs for ventilators in other parts of the world.

“Different things may be easier to build in different places,” he said. “There may be great value in having a portfolio of designs that are accessible to manufacturers from around the planet.”

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters.

Coronavirus information
Coronavirus information
The Zero Canada Project provides resources to help you manage your health, your finances and your family life as Canada reopens.
Visit the hub

In the interests of public health and safety, our coronavirus news articles are free for anyone to access. However, The Globe depends on subscription revenue to support our journalism. If you are able, please subscribe to globeandmail.com. If you are already a subscriber, thank you for your support.

Your subscription helps The Globe and Mail provide readers with critical news at a critical time. Thank you for your continued support. We also hope you will share important coronavirus news articles with your friends and family. In the interest of public health and safety, all our coronavirus news articles are free for anyone to access.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies